Coronary biomarker discovery and patient-endotyping platform.
| Date | Round | Amount |
|---|---|---|
| Apr 2024 | Funding round Cambridge-based PlaqueTec raised $8M in equity led by Lord Moynihan of Chelsea and the Future Fund for its coronary-disease biomarker platform. | $8M |
Tap an investor to see what else they have backed.
Data is community-curated and may be incomplete.